Login / Signup

Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti-PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial.

Timothée OlivierVinay Prasad
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Keyphrases
  • randomized controlled trial
  • dna damage
  • study protocol
  • cell cycle
  • combination therapy
  • open label
  • clinical trial
  • cell proliferation
  • systematic review
  • meta analyses